FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
22/07/2023
Voltar para busca
Dado oficial do USPTO
EXOCORRECT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
EXOCORRECT
ST13
US500000079330721Classe
5, 42, 44
Pedido
79330721
Registro
6998500
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
22/07/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
23/07/2021
Data de registro
14/03/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/03/2023
Última transação
14/03/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
WOLD, BARBARA NIELSEN
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Evox Therapeutics Limited
Representantes
Nancy Sabarra Fross Zellnick Lehrman & Zissu, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and substances for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; pharmaceutical preparationsa drug delivery system comprising genetically engineered or purified exosomes in the form of a liquid solution or lyophilised preparation for therapeutic use for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; pharmaceutical preparationsexosomes to deliver protein or nucleic acids or viral vectors for genetic therapy; medicine for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; Medical preparations for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; biological preparations for medical purposes for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; biological preparations for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders; biological preparations comprising exosome for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; biological preparations comprising a therapeutic target protein-loadednucleic acid-loaded or virus-loaded exosome for the treatment of genetic diseasesrespiratory diseasescancer; biological reagents for medical use; biological preparations for medical purposesfor the prevention and treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; mixed biological preparations for the prevention and treatment of infectious diseases; pharmaceuticalsmedicinesbiologicsbiotherapeuticsbiosimilars and therapeuticsEV-based nucleic acid therapeutic agents for the prevention and treatment of infections or disease; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint/ligament strain/tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders
Classe 42
Scientificmedical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; scientific research and analysis services; biological research; clinical research in the field of transformational therapeutics; providing medical and scientific research information in the field of filtration of exosomes from cultured cells or blood; scientific investigations for medical purposes; scientific laboratory services; medical laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of genetic diseasescancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders; consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; informationadvisory and consultancy services relating to the aforesaidscientificmedical and pharmaceutical research and development servicespharmaceutical drug development servicesresearch and development of pharmaceutical preparationsscientific research and analysis servicesbiological researchclinical research in the field of transformational therapeuticsproviding medical and scientific research information in the field of filtration of exosomes from cultured cells or bloodscientific investigations for medical purposesscientific laboratory servicesmedical laboratory serviceslaboratory research services relating to pharmaceuticalsresearch and development in the field of biotherapeutics for the treatment of genetic diseasescancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disordersbiotechnologypharmaceutical research and development and genetic sciencelaboratory diagnosticsmedical analysis services relating to the diagnosis and treatment of persons provided by medical laboratories
Classe 44
Medical services; medical and pharmaceutical consultancy; medical diagnosticsmedical testingmonitoringreporting services for diagnostic or treatment purposes; medical analysis services for the diagnosis and treatment of persons and for the diagnosis and treatment of genetic diseases; medical examination services; medical treatment services in the field of biotherapeutics for the treatment of infectious diseasescancerneurological disordersneurodegenerative disordersinflammatory disordersrare diseasesgenetic and metabolic disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; medical screening; medical monitoringtestinginspection and analysis services relating to the diagnosis and treatment of cancerviral and bacterial based infections and diseases; medical monitoringtestinginspection and analysis services relating to the diagnosis and treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders; informationadvisory and consultancy services relating to the aforesaidmedical servicesmedical and pharmaceutical consultancymedical diagnosticsmedical testingmonitoringreporting servicesmedical analysis services for the diagnosis and treatment of persons and for the diagnosis and treatment of genetic diseasesmedical examination servicesmedical treatment services in the field of biotherapeutics for the treatment of infectious diseasescancerneurological disordersneurodegenerative disordersinflammatory disordersrare diseasesgenetic and metabolic disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseasesmedical screeningmedical monitoringtestinginspection and analysis services relating to the diagnosis and treatment of cancerviral and bacterial based infections and diseasesmedical monitoringtestinginspection and analysis services relating to the diagnosis and treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tears and ligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/06/2023
FIMP
FINAL DISPOSITION PROCESSED
27/06/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/06/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
14/03/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
14/03/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/12/2022
PUBO
PUBLISHED FOR OPPOSITION
27/12/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/11/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
21/11/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/11/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
21/11/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/10/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/10/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/10/2022
RFNT
REFUSAL PROCESSED BY IB
10/05/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/04/2022
RFRR
REFUSAL PROCESSED BY MPU
21/04/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/04/2022
CNRT
NON-FINAL ACTION WRITTEN
19/04/2022
DOCK
ASSIGNED TO EXAMINER
19/04/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/01/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EXOCORRECT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.